Yusuke Higuchi

Title: Yusuke Higuchi: Innovator in Carcinostatic Agents

Introduction

Yusuke Higuchi is a notable inventor based in Suita, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as effective carcinostatic agents. His work is characterized by a focus on stability and efficacy in pharmaceutical applications.

Latest Patents

Higuchi holds a patent for a sulfonic acid salt compound of a 4-carbamoyl-5-hydroxy-imidazole derivative. The objective of this patent is to provide a stable SM-108 derivative that is effective as a carcinostatic agent. This SM-108 derivative is particularly noted for its good storage stability. The invention involves producing an organic sulfonic acid salt compound of SM-108, which can lead to the creation of a crystalline SM-108 compound with a trace amount of an organic carboxylic acid. This is achieved by using an aqueous solution of the organic sulfonic acid salt of SM-108 and adding an alkali metal salt of an organic carboxylic acid to neutralize the solution, resulting in crystal precipitation.

Career Highlights

Yusuke Higuchi is currently employed at Fujifilm Corporation, where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing the understanding and application of carcinostatic agents. Higuchi's dedication to research and development has positioned him as a key figure in his field.

Collaborations

Higuchi collaborates with esteemed colleagues such as Nobuo Kato and Chihiro Kondo. Their combined expertise contributes to the advancement of their projects and enhances the innovative capacity of their team.

Conclusion

Yusuke Higuchi's contributions to the field of medicinal chemistry, particularly through his patent on stable carcinostatic agents, highlight his role as an influential inventor. His work at Fujifilm Corporation and collaborations with notable colleagues further underscore his impact on pharmaceutical innovations.